Breast Biopsy Market Projected to Reach USD 4 Billion by 2030 with Increasing Demand for Minimally Invasive Procedures

 

According to Next Move Strategy Consulting, the global Breast Biopsy Market is poised to witness a substantial growth, reaching a projected value of USD 4 billion by 2030. This robust growth is anticipated to be driven by an 9% CAGR from 2024 to 2030, attributed to rising incidences of breast cancer, technological advancements in diagnostic imaging, and growing awareness regarding early detection and treatment.

Download FREE Sample Report: https://www.nextmsc.com/breast-biopsy-market/request-sample

Rising Incidence of Breast Cancer Fuels Market Demand

The alarming rise in breast cancer cases globally is a primary factor propelling the demand for effective diagnostic procedures like breast biopsies. According to WHO data, in 2020 alone, 2.3 million women were diagnosed with breast cancer, making it one of the most common cancers worldwide. The surge in such cases has necessitated the adoption of precise diagnostic techniques like fine-needle aspiration, core needle biopsy, and stereotactic biopsy, which help in early detection and treatment planning.

Innovations in 3D Scanning Technologies Drive Market Growth

Recent advancements in 3D mammography and metabolic imaging have significantly enhanced the accuracy of breast cancer detection, providing detailed insights into tumor characteristics. These cutting-edge imaging techniques are increasingly being integrated with breast biopsy procedures, allowing for improved visualization and precise sample collection, thereby reducing false-negative results and enhancing patient outcomes.

Market Dynamics: Opportunities and Challenges

While the breast biopsy market is experiencing steady growth, several challenges persist. Risks associated with biopsy procedures, such as swelling, bruising, soreness, and potential infections, continue to hinder patient confidence. However, the development of less invasive alternatives like vacuum-assisted biopsy, image-guided biopsy, and liquid biopsy are creating new opportunities, offering safer and more effective options for patients.

In addition, the rising focus on funding and awareness programs is expected to boost market growth. Moreover, regional initiatives such as the Goa Government’s free breast cancer screening program, aimed at reaching one lakh women, underline the growing emphasis on early detection.

Inquiry Before Buying: https://www.nextmsc.com/breast-biopsy-market/inquire-before-buying

Segmentation Analysis: Broadening Scope of Application

The Breast Biopsy Market is categorized based on type, product, guidance, and application:

• By Type: Includes needle breast biopsy (core needle, fine-needle aspiration, vacuum-assisted), open surgical biopsy, and liquid biopsy.
• By Product: Covers biopsy needles, tables, localization wires, guidance systems, and assay kits.
• By Guidance: Involves image-guided techniques (mammography, ultrasound, MRI) and liquid biopsy methods (NGS, PCR-based).
• By Application: Spans early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring.

North America Leads the Market with Rising Demand for Minimally Invasive Techniques

North America is currently the dominant region in the breast biopsy market, attributed to its widespread adoption of needle-based biopsy procedures. The demand for minimally invasive methods such as stereotactic biopsy, which uses mammography for accurate identification, is rapidly increasing. Additionally, heightened awareness about early-stage breast abnormalities and on-time treatment is expected to continue driving market growth in this region.

Conversely, the Asia-Pacific region is set to exhibit a steady rise due to advancements in healthcare infrastructure in emerging economies like China, India, and South Korea. The adoption of innovative diagnostic technologies like polymerase chain reaction (PCR) and next-generation sequencing (NGS), which detect genomic mutations, is expected to enhance early diagnosis rates in this region. Furthermore, non-governmental organizations (NGOs) conducting breast cancer screening programs are also contributing to the market’s expansion.

Competitive Landscape: Key Players Focus on Innovation and Strategic Partnerships

Leading companies in the breast biopsy market include:

• Epic Sciences
• F. Hoffmann-La Roche AG
• Bio-Rad Laboratories, Inc.
• Janssen Diagnostics
• Biocept, Inc.
• Guardant Health, Inc.
• Myriad Genetics
• Adaptive Biotechnologies
• Fluxion Biosciences, Inc.
• Biodesix

These players are focusing on collaborations, innovations, and product launches to strengthen their market position. For instance, in February 2022, Epic Sciences partnered with Fulgent Genetics to enhance its DefineMBC test, offering comprehensive metastatic breast cancer (MBC) profiling. Similarly, in December 2021, F. Hoffmann-La Roche AG launched its AI-based digital pathology algorithms, assisting pathologists in accurate image analysis and classification of breast cancer.

Also, Browse Related Reports:

• Explore the Thailand Disabled and Elderly Assistive Device Market Report
• Discover Insights into the Taiwan Disabled and Elderly Assistive Device Market
• Learn More About the Sweden Disabled and Elderly Assistive Device Market

For more information, please contact:

Next Move Strategy Consulting

E-Mail: info@nextmsc.com

Direct: +1-217-650-7991

Website: www.nextmsc.com

Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube

 

About Next Move Strategy Consulting:

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.